Roche launches Warp Drive antibiotic collaboration for $387m
October 16, 2017Sales and Marketing Antibiotics, Roche, biotech, drugs, pharma, pharmaceutical
Roche had tentatively begun to re-enter the antibiotic space, but it has now signalled its growing intention to move in …
Top Ten most popular articles on Pharmafile.com this week
October 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, pharmaceuticals, top ten
It’s been another packed week in the industry, with one of the biggest takeaways being that childhood obesity has rocketed …
Breakthrough study could revolutionise MS treatment
October 13, 2017Medical Communications, Research and Development biotech, drugs, multiple sclerosis, pharma, pharmaceutical
The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from …
BMS agrees deal on Opdivo availability through Cancer Drugs Fund for head and neck cancer
October 13, 2017Sales and Marketing BMS, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, NICE, opdivo, pharma, pharmaceutical
Thanks to successful negotiation of a managed access agreement, NICE has announced its recommendation of Bristol-Myers Squibb’s Opdivo (nivolumab) for …
Free Webinar: EudraVigilance changes and the impact on MAHs
October 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance
Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.
First leprosy vaccine makes initial step towards human use
October 13, 2017Medical Communications, Research and Development biotech, drugs, leprosy, pharma, pharmaceutical
A vaccine for leprosy, developed by the Infectious Disease Research Institute (IDRI) and with the financial support of the American …
Strong IBS and constipation Phase 3 data sends Ardelyx shares rocketing 60%
October 12, 2017Research and Development Ardelyx, pharma, pharmaceuticals, tenapanor
Ardelyx has confirmed that its NHE3 inhibitor tenapanor met all its primary and secondary endpoints in the study of its …
Epidemic preparedness: Protecting the world from the next infectious disease
October 12, 2017CEPI, biotech, drugs, pharma, pharmaceutical
Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness, details the lessons learned from the Ebola outbreak and the …
Aerie’s glaucoma drug gets strong preliminary FDA opinion
October 12, 2017Sales and Marketing Aerie, Aerie Pharmaceutical, FDA, Glaucoma, Rhopressa, pharma
In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil) effectively …
NICE gives final draft guidance on two key cancer drugs
October 12, 2017Sales and Marketing Bayer, CDF, Cancer, Cancer Drugs Fund, Erivedge, NICE, Roche, Stivarga
NICE has announced it has published its final draft guidance for two cancer treatments, covering Bayer’s Stivarga (regorafenib) in the …
MSD gives up on cholesterol drug, despite positive results
October 12, 2017Medical Communications, Sales and Marketing MSD, Merck, biotech, cholesterol, drugs, pharma, pharmaceutical
MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …
Sanofi set for €170 million expansion of vaccine facility
October 12, 2017Manufacturing and Production Sanofi, Sanofi Pasteur, biotech, drugs, influenza, pharma, pharmaceutical
Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection …
Childhood obesity increased 10-fold over last four decades
October 11, 2017Research and Development biotech, drugs, obese, obesity, pharma, pharmaceutical
An analysis of childhood and teenage obesity levels around the world have revealed that the numbers who are considered dangerously …
Lupin scoops up women’s health specialist Symbiomix for $150 million
October 11, 2017Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma
The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …
Moffitt scientists discover new applications for Novartis’s Zykadia
October 11, 2017Research and Development Cancer, Moffitt, NSCLC, ceritinib, lung cancer, zykadia
Through the use of molecular screening, functional proteomics and computer-based modelling, researchers from the Moffitt Cancer Center have been working …
Mylan and Biocon Neulasta biosimilar knocked back by FDA
October 11, 2017Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta, biotech, drugs, pharma, pharmaceutical
Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …
Allergan settles gender discrimination case for $4m
October 11, 2017Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …
NHS Scotland appoints new Chief Scientist
October 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Scotland, biotech, drugs, pharma, pharmaceutical
NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill …
Use of antacids found to promote liver disease
October 10, 2017Manufacturing and Production, Research and Development biotech, drugs, liver disease, pharma, pharmaceutical
A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …
Scottish government reveals extra funding for mental health
October 10, 2017Manufacturing and Production, Medical Communications Scotland, biotech, drugs, mental health, pharma, pharmaceutical
The Scottish government, on Mental Health Day, has revealed that it will boost spending on mental health services by £500,000. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
